Literature DB >> 16254996

Neural mechanisms of freezing and passive aversive behaviors.

Thomas Jhou1.   

Abstract

Cues that predict aversive outcomes often produce marked inhibitions of behavior known as freezing, but it is unknown exactly what neural pathways cause this inhibition. The amygdala and bed nucleus of the stria terminalis, along with their projections to the periaqueductal gray, are strongly implicated in freezing, but it is not known how these structures inhibit motor output. The median raphe nucleus (MRN), which contains a major population of serotonin neurons, has also been implicated in freezing, but the serotonin neurons themselves do not seem to be involved, leaving it uncertain which neurons in this area promote freezing. Our recent work suggests that GABAergic neurons just lateral to the MRN, but not within the MRN, regulate freezing via projections to midbrain dopamine neurons. Because freezing pathways may control a variety of other passive aversive behaviors, their elucidation may help understand the mechanisms of addictions and compulsions, which involve a failure of aversive outcomes to inhibit behavior. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16254996     DOI: 10.1002/cne.20734

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  19 in total

1.  Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat.

Authors:  Thomas C Jhou; Sheng-Ping Xu; Mary R Lee; Courtney L Gallen; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2012-06-06       Impact factor: 4.530

2.  The mesopontine rostromedial tegmental nucleus: an integrative modulator of the reward system.

Authors:  Heather N Lavezzi; Daniel S Zahm
Journal:  Basal Ganglia       Date:  2011-11

3.  Sources of input to the rostromedial tegmental nucleus, ventral tegmental area, and lateral habenula compared: A study in rat.

Authors:  Leora Yetnikoff; Anita Y Cheng; Heather N Lavezzi; Kenneth P Parsley; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2015-06-10       Impact factor: 3.215

Review 4.  Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions.

Authors:  Michel Barrot; Susan R Sesack; François Georges; Marco Pistis; Simon Hong; Thomas C Jhou
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

5.  The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta.

Authors:  Thomas C Jhou; Stefanie Geisler; Michela Marinelli; Beth A Degarmo; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2009-04-20       Impact factor: 3.215

6.  Long-term effect of cued fear conditioning on REM sleep microarchitecture in rats.

Authors:  Vibha Madan; Francis X Brennan; Graziella L Mann; Apryle A Horbal; Gregory A Dunn; Richard J Ross; Adrian R Morrison
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

7.  Cocaine drives aversive conditioning via delayed activation of dopamine-responsive habenular and midbrain pathways.

Authors:  Thomas C Jhou; Cameron H Good; Courtney S Rowley; Sheng-Ping Xu; Huikun Wang; Nathan W Burnham; Alexander F Hoffman; Carl R Lupica; Satoshi Ikemoto
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

8.  The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses.

Authors:  Thomas C Jhou; Howard L Fields; Mark G Baxter; Clifford B Saper; Peter C Holland
Journal:  Neuron       Date:  2009-03-12       Impact factor: 17.173

9.  Modulation of locomotor activation by the rostromedial tegmental nucleus.

Authors:  Heather N Lavezzi; Kenneth P Parsley; Daniel S Zahm
Journal:  Neuropsychopharmacology       Date:  2014-08-28       Impact factor: 7.853

Review 10.  An update on the connections of the ventral mesencephalic dopaminergic complex.

Authors:  L Yetnikoff; H N Lavezzi; R A Reichard; D S Zahm
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.